Epidermal growth factor receptor ectodomain in the urine of patients with squamous cell carcinoma.
In this study we determined the levels of the epidermal growth factor receptor (EGFR) in the urine of patients with squamous cell carcinoma compared to levels in the urine of normal volunteers and patients with nonsquamous cell carcinoma. A 24-h urine specimen was collected from 50 normal volunteers, 50 patients with nonsquamous cell carcinoma, and 42 patients with squamous cell carcinoma. An ELISA using mAbs to the external domain of the EGFR was used to measure levels of the receptor in the urine samples. Measurement of the EGFR ectodomain in the 24-h urine specimens showed detectable levels in 15 (36%) of 42 squamous cell carcinoma patients compared to 3 (6%) of 50 controls and 8 (16%) of 50 nonsquamous patients. It was also observed that 10 (53%) of 19 patients with metastatic squamous cell carcinoma had detectable EGFR ectodomain levels compared to 5 (22%) of 23 squamous cell patients with localized disease. Thus, we concluded that the EGFR ectodomain was detectable in the urine in a significantly higher number of patients with squamous cell carcinoma than normal volunteers or patients with nonsquamous cell carcinoma.
Witters
L M
LM
Department of Medicine and Center for Biostatistics and Epidemiology, The Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
Curley
E M
EM
Kumar
R
R
Chinchilli
V M
VM
Harvey
J P
JP
Crebbin
V
V
Harvey
H A
HA
Lipton
A
A
D016475:3T3 Cells; D000230:Adenocarcinoma; D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001943:Breast Neoplasms; D002294:Carcinoma, Squamous Cell / Q000652:urine*; D003110:Colonic Neoplasms; D004797:Enzyme-Linked Immunosorbent Assay; D066246:ErbB Receptors / Q000032:analysis*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000652:urine*; D012016:Reference Values; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D066246:ErbB Receptors